|
TP53INP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.2591999999988E-05 |
| Normal-vs-Stage3 |
6.185200E-04 |
| Normal-vs-Stage4 |
2.413800E-01 |
| Stage1-vs-Stage2 |
8.443500E-02 |
| Stage1-vs-Stage3 |
4.819200E-01 |
| Stage1-vs-Stage4 |
1.798240E-02 |
| Stage2-vs-Stage3 |
9.231700E-02 |
| Stage2-vs-Stage4 |
9.817500E-04 |
| Stage3-vs-Stage4 |
4.365800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.61359994652355E-09 |
| Normal-vs-Asian |
1.352210E-01 |
| Caucasian-vs-AfricanAmerican |
9.800400E-01 |
| Caucasian-vs-Asian |
3.436200E-01 |
| AfricanAmerican-vs-Asian |
4.072600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.33689725956287E-11 |
| Male-vs-Female |
5.134800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.79669999988974E-07 |
| Normal-vs-Extreme_Weight |
1.30673249998381E-13 |
| Normal-vs-Obese |
5.62790036795491E-10 |
| Normal-vs-Extreme_Obese |
7.460600E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.447600E-01 |
| Normal_Weight-vs-Obese |
5.921200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.344980E-01 |
| Extreme_Weight-vs-Obese |
4.542600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.263400E-01 |
| Obese-vs-Extreme_Obese |
2.420000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.423600E-03 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
4.661400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.000000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.444400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.266600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.098800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.498800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.200800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.6242562850266E-12 |
| Normal-VS-Type2 PRCC |
1.44849999994534E-07 |
| Normal-VS-KIRP CIMP |
4.852200E-01 |
| Normal-VS-Unclassified PRCC |
3.50900000001264E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.221100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.19030000025988E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
7.675600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.609500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.056400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.72730000000243E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.21160004041121E-09 |
| Normal-vs-N1 |
3.235300E-04 |
| Normal-vs-N2 |
2.244600E-01 |
| N0-vs-N1 |
1.162250E-01 |
| N0-vs-N2 |
2.756600E-01 |
| N1-vs-N2 |
6.037400E-01 |
|
|
